Utpal Nandi

1.5k citations
101 papers · 1.1k indexed · h-index 17
Topics
Drug Transport and Resistance Mechanisms (18 papers)Pharmacogenetics and Drug Metabolism (13 papers)Pharmacological Effects of Natural Compounds (9 papers)

In The Last Decade

Utpal Nandi

94 papers receiving 1.1k citations

Peers

Utpal Nandi
Comparison fields: 5 of 113
  • Molecular Biology 377
  • Pharmacology 252
  • Pharmacology 228
  • Oncology 213
  • Organic Chemistry 196
Replace Gurdarshan Singh with:
Gurdarshan Singh India
Ziru Dai China
Jinping Hu China
Guangbo Ge China
Javadi Monisha India
Young‐Mi Kim South Korea
Su‐Lan Hsiu Taiwan
Shatadal Ghosh India
Katarína Bauerová Slovakia
Nand Kishor Roy India
Utpal Nandi relative to Gurdarshan Singh India Gurdarshan Singh's profile →
Citations per field
00.5×
Gurdarshan Singh · 1×
Citations per year

Countries citing papers authored by Utpal Nandi

Since Specialization
Citations

This map shows the geographic impact of Utpal Nandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Utpal Nandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Utpal Nandi more than expected).

Fields of papers citing papers by Utpal Nandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Utpal Nandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Utpal Nandi. The network helps show where Utpal Nandi may publish in the future.

Co-authorship network of co-authors of Utpal Nandi

This figure shows the co-authorship network connecting the top 25 collaborators of Utpal Nandi. A scholar is included among the top collaborators of Utpal Nandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Utpal Nandi. Utpal Nandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 6
5 4
6 0
7 1
8 11
9 2
10 4
11 15
12 8
13 9
14 6
15 4
16 8
17 15
18 11
19 13
20 7

About Utpal Nandi

Utpal Nandi is a scholar working on Pharmacology, Pharmacology and Pharmaceutical Science, having authored 101 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects of Natural Compounds (9 papers). The work is most often cited by research in Pharmacology (228 citations), Pharmacology (252 citations) and Complementary and alternative medicine (105 citations). Utpal Nandi has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Gurdarshan Singh, Ashish Dogra, Abhishek Gour, Debaraj Mukherjee, Priya Wazir, Mousumi Pal, Ajay Kumar, Tapan Kumar Pal, Sandip B. Bharate and Swarnendu Bag. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026